As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how ...

An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers ...

Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to the lowest prices paid by ...

In the second part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, describes why this technology is essential for pharmaceutical safety and efficacy.

The acquisition of Cryoport’s specialty courier business is now finalized, with a value of approximately $200 million.

In the first part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, defines the term, and explains how ...

In the final part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, illustrates how data-driven ...

An Applied Clinical Trials article explores the complex and often conflicting perspectives of sponsors, CROs, and research sites on fair market value in clinical trial budgeting, emphasizing the need ...

A systematic review determines if adult patients with language barriers are less likely to use the video-based virtual care option, while exploring equity and accessibility gaps when it comes to ...

In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional ...

In an interview with Applied Clinical Trials, Jim Kremidas, executive director of the Association for MultiSite Research Corporations, discussed how partnering with multisite clinical research ...